Law and Regulations

Latest News

Congress, CMS Must Take Action to Mitigate Impact of ‘DIR Hangover’
Congress, CMS Must Take Action to Mitigate Impact of ‘DIR Hangover’

April 17th 2024

A Q&A with Douglas Hoey, CEO of NCPA, on how the new provision from CMS requiring DIR fees at the point of sale is impacting independent pharmacies in 2024.

Supreme Court Considers Mifepristone Limits in First Case Since Dobbs
Supreme Court Considers Mifepristone Limits in First Case Since Dobbs

March 28th 2024

Independent Pharmacies Continue to Face Financial Hardships as the Clock Ticks on PBM Reform
Independent Pharmacies Continue to Face Financial Hardships as the Clock Ticks on PBM Reform

March 7th 2024

Government, Industry Leaders Address the Growing Issue of PBM Practices
Government, Industry Leaders Address the Growing Issue of PBM Practices

March 5th 2024

Breaking: CVS, Walgreens to Begin Mifepristone Dispensing This Month
Breaking: CVS, Walgreens to Begin Mifepristone Dispensing This Month

March 1st 2024

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.